Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these ...

Until the U.S. addresses the extreme concentration in the infant formula industry, the country is just one plant closure away ...

The special sauce of primary care will not be saved until the overwhelming number of quality metrics that primary care ...

Scientists are frustrated that the USDA again failed to include basic information about H5N1 genetic sequences from cows when ...

The new funding led by General Catalyst and 7wireVentures values Transcarent at $2.2 billion, will be used for AI projects, ...

After years on the rise, the U.S. maternal mortality rate decreased in 2022, new government data show. But maternal health ...

A House subcommittee investigating the "lab leak" theory of Covid origins accuses EcoHealth of misrepresenting its virus ...

Extensive testing of pasteurized commercially purchased milk and other dairy products from 38 states found no evidence of ...

To answer those questions, researchers launched a large, 10-year study in 2015 to understand the biological impact of ...

The FTC is broadening its campaign to curb alleged patent abuses by the pharma industry, disputing over 300 patent listings ...

Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it's backing out.

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us ...